Loading Events

« All Events

  • This event has passed.

Maryland Psychiatric Society & Southern Psychiatric Association Joint Meeting

September 22 @ 6:15 pm - September 23 @ 9:30 pm

We were very disappointed to have to cancel the in-person Baltimore meeting we had planned in September.  However, despite bring faced with challenging times and much uncertainty we are excited to offer you this FREE (for MPS & SPA members), virtual CME meeting!Featuring timely and outstanding presentations, well known speakers and virtual happy hours we are confident you will agree that this meeting is one you don’t want to miss. You are welcome to join us for as many sessions as you can attend! Please see below for more information, including registration information. Once your registration has been submitted you will be emailed a link for the meeting as the event approaches. Two hours of CME available per day.

 

Dates: September 22nd and 23rd

Time: 6:15 – 8:30PM (Eastern time)

SPEAKER DISCLOSURE INDEX

 

September 22nd Agenda:

6:15                                         Welcome: Margaret Cassada, MD: SPA President

6:30-7:30                                 Ethics: Panel Session

  • Annette Hanson, MD: Ethical Issues in Correctional Psychiatry
  • Pamela McPherson MD, FAPA: Whistleblowing and Ethics: An Investigation of the ICE Detention Centers

 

7:30-8:30                                 Treating Geriatric Patients:  Panel Session

  • Joseph Bienvenu, MD, PhD: Psychiatric Morbidity after Critical Illness/Intensive Care
  • Robert Roca, MD, MPH: Measuring the Quality of Dementia Care: Do We Have it Right?

8:30-9:30                                 Social Reception via Zoom

 

 

September 23rd Agenda:

6:15                                         Welcome: Mark Ehrenreich, MD: MPS President

6:30-7:30                                 Opioid Update: Panel Session

  • George Kolodner, MD, DLFAPA: Pharmacological Management of Opioid Use Disorders
  • Sunil Khushalani, MD : Pharmacological Management of Opioid Use Disorders

 

7:30-8:30                                 COVID-19: Panel Session

  • David A. Casey, MD: Coronavirus and Psychiatry
  • Robert Caudill, MD: We’re all Telepsychiatrists Now: Irreversible Changes in the Field Brought on by the COVID-19 Response

 

8:30-9:30                                 Social Reception via Zoom

 

 

CLICK HERE FOR SPA/MPS MEMBER ONLY REGISTRATION

 

CLICK HERE FOR NON-MEMBER TWO DAY REGISTRATION

 

CLICK HERE FOR NON-MEMBER ONE DAY REGISTRATION

 

CLICK HERE FOR NON-MEMBER RESIDENT/FELLOW REGISTRATION

 

 

Accreditation 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychiatric Association (APA) and The Maryland Psychiatric Society. The APA is accredited by the ACCME to provide continuing medical education for physicians.

Designation The APA designates this live activity for a maximum of 4 AMA PRA Category 1 Credits (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity..

 

Learning Objectives:

Attendees will understand the historical and legal basis for privacy protections

Attendees will learn the limitations and reasoning behind limitations on privacy

Attendees will be cognizant of emergency trends in legislation that threaten privacy

Attendees will be able to describe a formal model of ethical decision making.

At the conclusion of this activity, physicians will be able to discuss common forms of physical and neuropsychiatric difficulties in survivors of critical illness, what is known about risk factors, and how they may help patients and families recover.

Describe the process by which the dementia quality measures were developed;

List the measures in the Dementia Management Quality Measure Set Update published in the American Journal of Psychiatry (2020);

Consider the implications of this measure set for their practice.

The participants will be able to discuss the historical and current context of Opioid Use Disorder

The participants will be able to describe the FDA approved medications for the management of opioid use disorder

Details

Start:
September 22 @ 6:15 pm
End:
September 23 @ 9:30 pm

Organizer

Southern Psychiatric Association
Phone:
(410) 938-3403
Email:
Website:
http://sopsych.org/

The Maryland Psychiatric Society, Inc. District Branch of the American Psychiatric Association
1101 Saint Paul Street, Suite 305 Baltimore, Maryland 21202-6407

Privacy Notice | Phone: (410) 625-0232 / Fax: (410) 625-0277

© 2020 The Maryland Psychiatric Society, Inc. All Rights Reserved. Web Design & Marketing by G.1440